309 results
8-K
EX-99.1
CRVO
CervoMed Inc
15 May 24
CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates
5:06pm
to increased accounting/audit fees, insurance costs, headcount costs, stock-based compensation expense due to additional stock options granted
8-K/A
EX-99.2
554rfotalzkw
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
j1jhb1 ondr09j2ubh2
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-99.2
qkyegqsfpm0ejyxc5fg
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
8-K
EX-16.1
28hxvfht3
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
424B3
u22rse9b
13 Jul 23
Prospectus supplement
4:32pm